SystImmune

systimmune.com

Syst Immune, Inc. is a biopharmaceutical company focused on developing novel therapeutic bi-specific and multi-specific antibodies, as well as antibody-drug conjugates (ADCs) for cancer treatment. The company aims to create biologics that systematically intervene in tumor microenvironments, directly attack tumors, and activate the immune system. With a strong R&D team and multiple active clinical trials, Syst Immune is positioned to capitalize on market opportunities in the US and Asia, seeking to bring innovative therapeutics to patients globally.